ERBB2 and triple-negative breast carcinoma: The development of molecular profiling techniques has further ensured this heterogeneity, and it is now possible to classify BRCA within, at least, three main subtypes: luminal, HER2-enriched (HER2+) and triple-negative breast cancer (TNBC).